Neurocrine Biosciences (0K6R.L) Stock Price
$151.7 0.6%
to add to portfolio
AI Score
-
Alternative
9 -
Fundamental
10 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Neurocrine Biosciences, AI stock picks, stock alerts and much more.
0K6R.L AI Stock Analysis
Financial Performance
Neurocrine Biosciences' last quarter revenue was $622.1M, a growth of 5.4% from the previous quarter and an impressive growth of 20.7% year over year. The gross profit stood at $614.1M, showing a quarterly increase of 6.9% and annual increase of 21.2%. Their operating income profit was $183.8M, up by 24.3% from the previous quarter and up by 22.3% year over year, indicating strong operational efficiency and business performance.
Stock Price
The stock is currently trading at $152.89 with an uptrend in the past month (8.7%) as well as in the past year (7.5%). The RSI value stands at a high level of 81.45 indicating that the stock might be overbought while its PE ratio is quite high at 209 which might indicate that it's overvalued compared to earnings.
Alternative Data Signals
The company has shown positive signs in alternative data signals too with website traffic increasing by 7.8%, job postings growing by about 1%, and social media followers on Twitter and Facebook also showing significant increases over time - all these factors point towards increased interest around Neurocrine Biosciences' work.
Conclusion
In conclusion, considering both financial performance indicators such as revenue trends, gross profit margins etc., along with positive alternative data signals like web traffic trends, job postings etc., we are bullish on Neurocrine Biosciences' stock.
Note: This AI Stock Analysis is based on data as of February 01. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Neurocrine Biosciences (0K6R.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Neurocrine Biosciences (0K6R.L), currently trading at $151.7, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0K6R.L
-
Neurocrine Biosciences, Inc.
-
Symbol
0K6R.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
15.4B
Similar Stocks
 |
Waters Corporation 0LTI.L |
$410.6 0.4% |
5 |
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$487.6 2.1% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$10.73 0.00% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.99 4.3% |
3 |
 |
Walgreens Boots Alliance 0LSZ.L |
$9.78 0.7% |
4 |
News
0K6R.L Alternative Data
Web Traffic
Neurocrine Biosciences receives an estimated 25504 monthly visitors to neurocrine.com.
-
Web Traffic
25504
-
Change from Previous Month
7.8%
-
3 Month Change
7%
News Mentions
Neurocrine Biosciences was mentioned 4 times in the news yesterday.
-
News Mentions
4
-
Daily Change
300%
-
1 Month Change
100%
-
3 Month Change
300%
Twitter Followers
Neurocrine Biosciences has 686 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.6% over the last month.
-
Twitter Followers
686
-
Daily Change
0.1%
-
1 Month Change
1.6%
-
3 Month Change
7.7%
Facebook Engagement
Neurocrine Biosciences has engaged 1 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
1
-
Daily Change
50%
-
1 Month Change
80%
-
3 Month Change
80%
LinkedIn Followers
68,336 are following Neurocrine Biosciences on LinkedIn, up by 2.2% over the last month.
-
LinkedIn Followers
68336
-
Daily Change
0.1%
-
1 Month Change
2.2%
-
3 Month Change
5.6%
Job Postings
Neurocrine Biosciences currenly has an estimated 92 open job postings, up by 9.5% over the last month.
-
Job Postings
92
-
Daily Change
9.5%
-
1 Month Change
9.5%
-
3 Month Change
16.5%
LinkedIn Employees
According to LinkedIn, Neurocrine Biosciences has 1,813 employees, up by 1.6% over the last month.
-
LinkedIn Employees
1813
-
Daily Change
0.1%
-
1 Month Change
1.6%
-
3 Month Change
5.5%
Business Outlook
-
Business Outlook
94
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
App Downloads
-
App Downloads
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
0K6R.L Financials
0K6R.L Key Metrics
-
Total Revenue
$622.1M
-
Net Income
$129.8M
-
Earnings per Share
$1.28
-
Free cash flow
$149.9M
-
EBITDA
$191.3M
-
EBITDA Ratio
0.307507
-
Total Assets
$3.5B
0K6R.L 2-year Revenue & Income
0K6R.L 2-year Free Cash Flow
0K6R.L Technicals
0K6R.L SMA
0K6R.L RSI
FAQ
What's the current price of Neurocrine Biosciences (0K6R.L) Stock?
The price of an Neurocrine Biosciences (0K6R.L) share is $151.7.
What's the market cap of Neurocrine Biosciences?
The current market cap of Neurocrine Biosciences is 15.4B.
Should I buy or sell 0K6R.L?
Multiple alternative data signals suggest that Neurocrine Biosciences stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Neurocrine Biosciences a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Neurocrine Biosciences stock. The bullish indicators suggest that Neurocrine Biosciences' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Neurocrine Biosciences (0K6R.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Neurocrine Biosciences stock, given the bullish outlook.
What are some stocks similar to Neurocrine Biosciences (0K6R.L) that investors often compare it to?
Neurocrine Biosciences (0K6R.L) is often compared to similar stocks such as Waters Corporation, Vertex Pharmaceuticals Incorporated, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for Neurocrine Biosciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Neurocrine Biosciences' stock price to be around $173.4 in 2026. Starting from the current price of $151.7, this represents a 14.3% change in price, indicating a bullish outlook for the stock.
How to buy Neurocrine Biosciences (0K6R.L) Stock?
Neurocrine Biosciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Neurocrine Biosciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.